1Ishak KG,Sharp HL,Schwarzenberg SJ.Metabolic errors and liver disease[M]// MacSween RNM,Burt AD,Portmann BC,etal.Pathology of the liver.4th ed.London:Churchill Livingstone,2002:155-256.
2Labrune P,Trioche P,Duvaltier I,et al.Hepatocellular adenomas in glycogen storage disease type Ⅰ and Ⅲ:a series of 43 patients and review of the literature[J].J Pediatr Gastroenterol Nutr,1997,24(3):276-279.
4Poe R,Snover DC.Adenomas in glycogen storage disease type 1.Two cases with unusual histologic features[J].Am J Surg Pathol,1988,12 (6):477-483.
同被引文献7
1Chou JY. The molecular basis of type 1 glycogen storage diseases. Curr Mol Med, 2001, 1 (1): 25-44.
2Dienstag JL, Isselbacher KJ. Tumors of the liver and biliary tract. In: Kasper DL, Braunwald E, Fauci AS, et al eds. Harrison's Principles of Internal Medicine. 16th ed. New York: McGraw-Hill Companies, 2004. 533-536.
3Bianchi L. Glycogen storage disease Ⅰ and hepatocellular tumours. Eur J Pediatr, 1993, 152 Suppl 1: S63-S70.
4Yoshikawa M, Fukui K, Kuriyama S, et al. Hepatic adenomas treated with percutaneous ethanol injection in a patient with glycogen storage disease type Ⅰ a. J Gastroenterol, 2001, 36 (1): 52-61.
